260 related articles for article (PubMed ID: 23030222)
1. Breast cancer intratumor genetic heterogeneity: causes and implications.
Ng CK; Pemberton HN; Reis-Filho JS
Expert Rev Anticancer Ther; 2012 Aug; 12(8):1021-32. PubMed ID: 23030222
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer intra-tumor heterogeneity.
Martelotto LG; Ng CK; Piscuoglio S; Weigelt B; Reis-Filho JS
Breast Cancer Res; 2014 May; 16(3):210. PubMed ID: 25928070
[TBL] [Abstract][Full Text] [Related]
3. Intratumor Heterogeneity in Breast Cancer.
Beca F; Polyak K
Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
[TBL] [Abstract][Full Text] [Related]
4. Intratumor and circulating clonal heterogeneity shape the basis of precision breast cancer therapy.
Ziogas DE; Spiliotis J; Lykoudis EG; Zografos GC; Roukos DH
Future Oncol; 2017 Jan; 13(2):113-116. PubMed ID: 27581662
[No Abstract] [Full Text] [Related]
5. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.
Campoy EM; Branham MT; Mayorga LS; Roqué M
BMC Cancer; 2019 Apr; 19(1):328. PubMed ID: 30953488
[TBL] [Abstract][Full Text] [Related]
6. Molecular heterogeneity in breast cancer: State of the science and implications for patient care.
Ellsworth RE; Blackburn HL; Shriver CD; Soon-Shiong P; Ellsworth DL
Semin Cell Dev Biol; 2017 Apr; 64():65-72. PubMed ID: 27569190
[TBL] [Abstract][Full Text] [Related]
7. Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.
Aleskandarany MA; Vandenberghe ME; Marchiò C; Ellis IO; Sapino A; Rakha EA
Pathobiology; 2018; 85(1-2):23-34. PubMed ID: 29428954
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.
Ng CK; Schultheis AM; Bidard FC; Weigelt B; Reis-Filho JS
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713166
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer.
Brooks MD; Burness ML; Wicha MS
Cell Stem Cell; 2015 Sep; 17(3):260-71. PubMed ID: 26340526
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.
Hong D; Fritz AJ; Zaidi SK; van Wijnen AJ; Nickerson JA; Imbalzano AN; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2018 Dec; 233(12):9136-9144. PubMed ID: 29968906
[TBL] [Abstract][Full Text] [Related]
11. Tumoral heterogeneity of breast cancer.
Roulot A; Héquet D; Guinebretière JM; Vincent-Salomon A; Lerebours F; Dubot C; Rouzier R
Ann Biol Clin (Paris); 2016 Dec; 74(6):653-660. PubMed ID: 27848916
[TBL] [Abstract][Full Text] [Related]
12. Intratumor heterogeneity: nature and biological significance.
Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of breast cancer: etiology and clinical relevance.
Almendro V; Fuster G
Clin Transl Oncol; 2011 Nov; 13(11):767-73. PubMed ID: 22082639
[TBL] [Abstract][Full Text] [Related]
14. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
[No Abstract] [Full Text] [Related]
15. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
Liang ZM; Chen Y; Luo ML
Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
[TBL] [Abstract][Full Text] [Related]
16. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
McGranahan N; Swanton C
Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
[TBL] [Abstract][Full Text] [Related]
17. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
18. Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy.
Koren S; Bentires-Alj M
Mol Cell; 2015 Nov; 60(4):537-46. PubMed ID: 26590713
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects.
Cherdyntseva NV; Litviakov NV; Denisov EV; Gervas PA; Cherdyntsev ES
Exp Oncol; 2017 Mar; 39(1):2-11. PubMed ID: 28361862
[TBL] [Abstract][Full Text] [Related]
20. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]